Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive Oliceridine for Postoperative Pain After Laparoscopic Cholecystectomy
ChiCTR2400092308Phase 4Not yet recruiting
- Sponsor
- Pidu District People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in postoperative pain (3 arms), sponsored by Pidu District People's Hospital. Primary endpoint: Incidence of moderate to severe pain at 0 hours after surgery. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400092308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092308.